tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VNRX Stock Latest News

Strategic Partnerships and Growth Potential Justify Buy Rating for VolitionRX
RatingsStrategic Partnerships and Growth Potential Justify Buy Rating for VolitionRX
8d ago
VNRX
VolitionRx signs co-marketing and services agreement with Hologic
PremiumThe Fly
VolitionRx signs co-marketing and services agreement with Hologic
9d ago
HOLX
VNRX
VolitionRX’s Strategic Partnership and Growth Potential Drive Buy Rating
PremiumRatings
VolitionRX’s Strategic Partnership and Growth Potential Drive Buy Rating
28d ago
VNRX
VolitionRx signs first human out licensing deal for APS
PremiumThe Fly
VolitionRx signs first human out licensing deal for APS
29d ago
VNRX
VolitionRx Ltd. Earnings Call: Key Insights and Challenges
PremiumCompany Announcements
VolitionRx Ltd. Earnings Call: Key Insights and Challenges
1M ago
VNRX
VolitionRx Reports Q2 2025 Financial Results and Strategic Progress
PremiumCompany AnnouncementsVolitionRx Reports Q2 2025 Financial Results and Strategic Progress
2M ago
VNRX
VolitionRx reports Q2 revenue $400K, consensus $375.72K
Premium
The Fly
VolitionRx reports Q2 revenue $400K, consensus $375.72K
2M ago
VNRX
VolitionRx announces pricing of $1.2M registered direct offering
Premium
The Fly
VolitionRx announces pricing of $1.2M registered direct offering
2M ago
VNRX
Advancements in VolitionRX’s Diagnostic Technology and Promising Market Position
PremiumRatings
Advancements in VolitionRX’s Diagnostic Technology and Promising Market Position
3M ago
VNRX
VolitionRx files to sell 23.44M shares of common stock for holders
PremiumThe Fly
VolitionRx files to sell 23.44M shares of common stock for holders
3M ago
VNRX
VolitionRX Stockholders Approve Key Proposals at Meeting
PremiumCompany Announcements
VolitionRX Stockholders Approve Key Proposals at Meeting
4M ago
8K
VNRX
VolitionRx’s Strategic Positioning and Growth Potential Justifies Buy Rating
PremiumRatings
VolitionRx’s Strategic Positioning and Growth Potential Justifies Buy Rating
4M ago
VNRX
VolitionRx initiated with a Buy at JonesResearch
PremiumThe FlyVolitionRx initiated with a Buy at JonesResearch
4M ago
VNRX
Tomi Environmental Solutions appoints Vanston as CFO
Premium
The Fly
Tomi Environmental Solutions appoints Vanston as CFO
4M ago
TOMZ
VNRX
VolitionRX Ltd. Earnings Call Reveals Promising Growth
Premium
Company Announcements
VolitionRX Ltd. Earnings Call Reveals Promising Growth
5M ago
VNRX
VolitionRx Reports Strong Q1 2025 Performance
PremiumCompany Announcements
VolitionRx Reports Strong Q1 2025 Performance
5M ago
VNRX
VolitionRX’s Promising Growth: Buy Rating Backed by Revenue Surge and Strategic Partnerships
PremiumRatings
VolitionRX’s Promising Growth: Buy Rating Backed by Revenue Surge and Strategic Partnerships
5M ago
VNRX
Options Volatility and Implied Earnings Moves Today, May 16, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, May 16, 2025
5M ago
SY
BRC
VolitionRx reports Q1 revenue $0.25M, consensus $1.08M
PremiumThe Fly
VolitionRx reports Q1 revenue $0.25M, consensus $1.08M
5M ago
VNRX
VolitionRX Signs New Capital Sales Agreement
PremiumCompany AnnouncementsVolitionRX Signs New Capital Sales Agreement
6M ago
8K
VNRX
VolitionRX’s Innovative Diagnostics and Promising Growth Drive Buy Rating with $2.50 Price Target
Premium
Ratings
VolitionRX’s Innovative Diagnostics and Promising Growth Drive Buy Rating with $2.50 Price Target
6M ago
VNRX
VolitionRx initiated with a Buy at H.C. Wainwright
Premium
The Fly
VolitionRx initiated with a Buy at H.C. Wainwright
6M ago
VNRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >